Literature DB >> 634183

Transthoracic ventricular defibrillation in the adult.

A A Adgey, N P Campbell, S W Webb, A L Kennedy, J F Pantridge.   

Abstract

Since the lower the energy used, the less the possible myocardial damage, two studies of 214 patients in ventricular fibrillation (VF) were conducted, using two types of defibrillators each charged to 200 Wsec and 100Wsec. In the first study, each defibrillator was charged to 200 Wsec (150-165 Wsec delivered). Up to three 200-Wsec shocks successfully converted 222 of 233 VF episodes. In 199 episodes, a single shock successfully removed the fibrillation. In 48 episodes in patients weighing more than 80 kg, VF was removed in 43 (90 percent). In the second study, from a stored energy of 100 Wsec, 74 to 82 Wsec of energy were delivered in the initial shock to treat 161 VF episodes in 94 patients. The first shock was successful in 101 (63 percent) of the 161 episodes. Up to three 100-Wsec shocks achieved 81 percent conversion in 52 episodes. A third 100-Wsec shock seldom succeeded. Using a sequence of 100 - 200 - 400 Wsec shocks, 93 (91 percent) of 102 episodes were successfully converted. There was not a single instance of failure to remove VF among the 214 patients with a maximal delivered energy of 330 Wsec. Thus, the direction towards the production of larger instruments storing more than 400 Wsec energy seems unwarranted.

Entities:  

Mesh:

Year:  1978        PMID: 634183

Source DB:  PubMed          Journal:  Med Instrum        ISSN: 0090-6689


  4 in total

1.  Ventricular defibrillation: problems of electrical management.

Authors:  J A Orpin; M Smith
Journal:  Can Fam Physician       Date:  1982-11       Impact factor: 3.275

2.  Monitoring normal and aberrant electrocardiographic activity from an endotracheal tube: comparison of the surface, esophageal, and tracheal electrocardiograms.

Authors:  J K Hayes; J L Peters; K W Smith; C M Craven
Journal:  J Clin Monit       Date:  1994-03

3.  Electrical requirements of defibrillation.

Authors:  G Koning; R Geuze; A J Meinema
Journal:  Br Heart J       Date:  1979-10

Review 4.  Targeting device therapy: genomics of sudden death.

Authors:  J Michael Frangiskakis; Barry London
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.